已收盘 12-12 16:00:00 美东时间
-0.210
-0.29%
Mizuho analyst Vikram Malhotra maintains BXP (NYSE:BXP) with a Outperform and lowers the price target from $82 to $79.
12-12 22:05
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Keybanc analyst Upal Rana upgrades BXP (NYSE:BXP) from Sector Weight to Overweight and announces $80 price target.
12-04 20:56
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
Wells Fargo analyst Blaine Heck maintains BXP (NYSE:BXP) with a Overweight and lowers the price target from $77 to $74.
11-26 00:08
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
Scotiabank analyst Nicholas Yulico maintains BXP (NYSE:BXP) with a Sector Perform and raises the price target from $77 to $81.
11-14 01:21
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's
10-30 00:47